webinar register page

Webinar banner
Paying for Cures: Self-Insured Employers Workshop
Durable, potentially curative therapies for genetic disorders and cancer have arrived. Short—even single dose—treatment regimens yield lasting health benefits, but large single payments will challenge the current reimbursement system.

In this virtual workshop the FoCUS Project will help you explore the impact of cell and gene therapies on your health benefit plans, survey the risks, and learn about solutions.

This intensive 1-day conference will help you:
* Understand how these therapies are different
* Explore new solutions and support resources
* Discover actionable and affordable steps to ensure sustainable coverage and access

This interactive workshop is ideal for:
* Self-insured employer health benefits and finance professionals
* Other advisors and partners such as self-insured employer brokers, consultants and stop-loss carriers

June 17, 2021
11:00am – 3:00pm Eastern via Web conference

About the FoCUS Project:

The MIT NEWDIGS consortium FoCUS Project (Financing and Reimbursement of Cures in the US) seeks to collaboratively address the need for new, innovative financing and reimbursement models for durable and potentially curable therapies that ensure patient access and sustainability for all stakeholders. Our mission is to deliver an understanding of financial challenges created by these therapies leading to system-wide, implementable precision financing models. This multi-stakeholder effort gathers developers, providers, regulators, patient advocacy groups, payers from all segments of the US healthcare system, and academics working in healthcare policy, financing, and reimbursement in this endeavor.

Jun 17, 2021 11:00 AM in Eastern Time (US and Canada)

Webinar logo
* Required information
Loading

By registering, I agree to the Privacy Statement and Terms of Service.

Register

Speakers

Jane F. Barlow, MD, MBA, MPH
Senior Advisor, FoCUS Project @Massachusetts Institute of Technology
Dr. Jane Barlow is a clinical and strategic executive consultant with over 25 years of healthcare leadership experience. She is Chief Clinical Officer of Real Endpoints, a market access company and serves as Senior Advisor to the MIT Center for Biomedical Innovation project on Financing of Curative Therapies. Dr. Barlow focuses on evaluating the economic impact and value of pharmaceuticals and diagnostics to aid in defining access and coverage strategies with a focus on outcomes and innovative contracting. Dr. Barlow previously held senior leadership positions at CVS Health, Medco Health Solutions and IBM. Her diverse background also includes positions with the U.S. military, federal government, industry and private practice.
Other Speakers TBA